Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard E Gendelman

Showing results (91-100 of 354) with videos related to

Pageof 36
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 19, 2010
Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeuticsAri S Nowacek, JoEllyn McMillan, Reagan Miller, et al.
Neurotoxicity Research|January 11, 2005
Neuroprotective strategies for HIV-1 associated dementiaHuanyu Dou, Jeffrey D Kingsley, R Lee Mosley, et al.
Journal of Neurochemistry|January 24, 2007
Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's diseaseMark P Thomas, Kathryn Chartrand, Ashley Reynolds, et al.
Journal of Neuroimmunology|January 2, 2007
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseChad Laurie, Ashley Reynolds, Ozlem Coskun, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2010
Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinaseHarris A Gelbard, Stephen Dewhurst, Sanjay B Maggirwar, et al.
Journal of Neuroimmunology|September 18, 2010
Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitisNan Gong, Jianuo Liu, Ashley D Reynolds, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Nanotechnology: a focus on nanoparticles as a drug delivery systemJeffrey D Kingsley, Huanyu Dou, Justin Morehead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegenerationJianuo Liu, Nan Gong, Xiuyan Huang, et al.
Journal of Visualized Experiments : Jove|December 24, 2010
Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugsShantanu Balkundi, Ari S Nowacek, Upal Roy, et al.
Neurobiology of Aging|October 9, 2012
CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's diseaseTomomi Kiyota, Howard E Gendelman, Robert A Weir, et al.
Pageof 36

Showing results (91-100 of 354) with videos related to

Sort By:
Pageof 36
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 19, 2010
Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeuticsAri S Nowacek, JoEllyn McMillan, Reagan Miller, et al.
Neurotoxicity Research|January 11, 2005
Neuroprotective strategies for HIV-1 associated dementiaHuanyu Dou, Jeffrey D Kingsley, R Lee Mosley, et al.
Journal of Neurochemistry|January 24, 2007
Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's diseaseMark P Thomas, Kathryn Chartrand, Ashley Reynolds, et al.
Journal of Neuroimmunology|January 2, 2007
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseChad Laurie, Ashley Reynolds, Ozlem Coskun, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2010
Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinaseHarris A Gelbard, Stephen Dewhurst, Sanjay B Maggirwar, et al.
Journal of Neuroimmunology|September 18, 2010
Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitisNan Gong, Jianuo Liu, Ashley D Reynolds, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Nanotechnology: a focus on nanoparticles as a drug delivery systemJeffrey D Kingsley, Huanyu Dou, Justin Morehead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegenerationJianuo Liu, Nan Gong, Xiuyan Huang, et al.
Journal of Visualized Experiments : Jove|December 24, 2010
Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugsShantanu Balkundi, Ari S Nowacek, Upal Roy, et al.
Neurobiology of Aging|October 9, 2012
CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's diseaseTomomi Kiyota, Howard E Gendelman, Robert A Weir, et al.
Pageof 36